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and so govern most critical cellular functions. Increasing evidence points to the molecular motor myosin 1c
as a prominent player in many signaling cascades, from the integrin-dependent signaling involved in cell mi-
gration to the signaling events underlying insulin resistance. Myosin 1c functions on these pathways both via
an important role in regulating lipid raft recycling and also via direct involvement in signaling cascades. This
review provides an overview of the functional involvement of myosin 1c in cellular signaling and discusses
the possible potential for myosin 1c as a target for drug-based treatments for human diseases.
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The regulation of cellular processes relies on dynamic communica-
tion between a given cell and its surroundings. This communication
often occurs via exposure to chemical signals (e.g. hormones, cytokines)
that bind membrane receptor proteins and trigger intracellular signal
transduction cascades. These signaling pathways are carefully coordi-
nated, interconnected and highly conserved networks of kinase effectorical Research, Wellcome Trust/
gdom. Tel.: +44 1223 763348
.
license.proteins and secondary messengers that amplify and integrate external
signals to produce distinct cellular responses (e.g. changes in gene
expression). In this manner, signaling cascades regulate a wide range
of fundamental processes, from cellular growth, differentiation, and ap-
optosis to migration and the immune response [1]. Some commonly
studied signal transduction pathways are the multichain immune
recognition receptor (MIR) pathways mediating immune response to
speciﬁc antigens/antibodies [2], the mitogen-activated protein (MAP)
kinase and Wnt signaling pathways regulating development [3,4], and
the insulin signaling pathway regulating blood glucose levels [5].
As in the case of most pathways involving the regulated transmis-
sion of a signal or other cargo throughout the cell, signal transduction
pathways are often associated with the myosin protein family. Myosin
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gy derived from ATP hydrolysis to transport cargo along actin ﬁlaments
or tether cargo at speciﬁc intracellular locations [6]. These myosin mo-
tors mediate many key cellular processes such as motility, cytokinesis,
organization of the actin cytoskeleton and, notably, signal transduction.
For example, myosins in class III are themselves protein kinases that
function directly in phototransduction signal cascades [7]. Furthermore,
myosin IX proteins serve as GTPase activating proteins (GAPs) that neg-
atively regulate Rho GTPases and so directly inﬂuence Rho signaling
pathways involved in actin remodeling/cell migration [7–9]; whereas
myosin VI itself is phosphorylated by p21-activated kinase (PAK) and
has been suggested to play a role in a PAK signaling pathwaymediating
membrane rufﬂing in response to epidermal growth factor stimulation
[10]. In addition, nonmuscle myosin II directs the cell surface localiza-
tion of receptors for inositol (1,4,5)-trisphosphate [11] and regulates
the function of the receptor tyrosine kinase discoidin domain receptor
1 (DDR1) in a signaling network effecting cell migration/spreading
[12]. Myosin IIA also plays a role in regulating the endocytosis of the cy-
tokine receptor CXCR4 and subsequent onset of stromal cell-derived
factor-1 alpha (SDF-1 alpha) signaling [13], and ﬁnally modulates the
internalization and downstream signaling pathways of the epidermal
growth factor receptor (EGFR) [14].
Recent insight into the intracellular roles of myosin 1c highlights this
myosin as another critical player in theﬁeld of cell signaling.Myosin 1c is
a single-headed, lowduty ratiomotorwith a three-part domain structure
similar to that found inmostmyosin proteins: it has anN-terminalmotor
domain that binds to actin andhydrolyzes ATP, a neck (lever-arm) region
that binds to three regulatory calmodulin light chains, and a tail domain
with a pleckstrin homology (PH) lipid-bindingmotif [15–17]. Themotor
localizes to the plasmamembrane and actin-rich structures near the cell
surface (e.g. rufﬂes/lamellipodia) as well as the cell nucleus and lipid
membranes throughout the cell [18,19]. This review will highlight the
broad impact of myosin 1c on cell signaling by discussing the involve-
ment of this myosin in many different intracellular signaling pathways.
The therapeutic implications of this involvement formyosin 1c in cell sig-
naling will then be explored.2. Overview of cellular functions of myosin 1c
Examining the distinguishing structural and kinetic features of my-
osin 1c provides insights into its general functions within the cell. Myo-
sin 1c is a ‘short-tailed’member of the myosin I family, containing only
the ﬁrst of the three existing myosin I tail homology domains. Such
short-tailed myosins are typiﬁed by slower ATPase rates than their
long-tailed counterparts in themyosin I family and thus have been classi-
ﬁed as slow ‘strain sensor’myosins [20]. Thesemyosin proteins appear to
have been designed either to transport/anchor heavy cargo or to crosslink
the stress-bearing actin ﬁlaments required for tethering or maintenance
of intracellular cortical tension [21,22]. This type of tethering/tension
modulating role for myosin 1c is further supported by the observation
that this myosin has a two-phase power stroke and so is well adapted
for maintaining signiﬁcant tension without continuous dissociation
from (and reassociation with) actin ﬁlaments [23].
Functional studies of myosin 1c indicate that the motor utilizes its
tension modulating/tethering capacities in a variety of critical cellular
processes. On the exocytic pathway, myosin 1c has been implicated in
the regulated secretion of glucose transporter 4 (GLUT4)-containing
vesicles [24,25]. Myosin 1c has also been shown to couple polymerizing
actin ﬁlaments to membranes to modulate force production during
compensatory endocytosis [26]. Furthermore, myosin 1c has been im-
plicated in the transport of aquaporin-2 (AQP2)-containing membrane
vesicles to the apical region of renal collecting duct cells [27], and is re-
quired to maintain the correct localization of the slit diaphragm protein
Neph1 at the podocyte membrane [28] and the proper localization of
sodium channels at collecting duct cell membranes [29].In addition to these roles in intracellular trafﬁcking, myosin 1c has
been widely implicated in the maintenance and organization of actin
rich structures at the cell periphery: for example, in the dynamic
rearrangement of the cortical actin network required for membrane ruf-
ﬂe formation in adipocytes [25,30]. Inmotile cells, myosin 1c plays a role
in lamellipodia dynamics [31], in the turning of growth cones to direct
neuronal cell motility [32], and in the transport of G-actin to the leading
edge of migrating epithelial cells [33]. Myosin 1c is also implicated in
cytoskeletal rearrangements within the lamellipodia and ﬁlipodia of
spreading B-cells [34]. On a more divergent functional note, a splice var-
iant ofmyosin 1cwith anN-terminal extension is targeted to the nucleus
and speculated to play a role in transcription and other nuclear processes
[19].
3. Myosin 1c in cell signaling: lipid raft regulation
Insight into the distinct molecular role of myosin 1c common to all
of these dynamic processes has been greatly enhanced by the recent
discovery that myosin 1c regulates lipid raft trafﬁcking and recycling
[35]. This function likely underlies many of the cellular roles for my-
osin 1c discussed above. As lipid rafts are intimately linked to cellular
signaling pathways, this discovery also targets myosin 1c as a major
player in intracellular signaling. This section will provide an overview
of the raft-based involvement of myosin 1c in cell signaling.
3.1. Lipid rafts and cell signaling
Over the last ﬁfteen years, the concept of lipid rafts has drastically
revised traditional theories of a passive and freely diffusing lipid-
protein cell membrane. These lipid rafts are membrane microdomains
characterized by a concentration of sphingolipids and cholesterol that
compartmentalize cellular processes by permitting the ordered sorting
and concentration of speciﬁc proteins within small membrane regions
[36,37]. Raftswere originally characterized by their resistance to extrac-
tion with non-ionic detergents, but recent advances in optical tech-
niques have made it possible to visually conﬁrm their presence [38].
The cohesiveness of a given lipid raft is based on lateral associations be-
tween its lipid components [36] and such cohesive regions of ordered
sphingolipid/cholesterol membrane have been identiﬁed in trafﬁcking
pathways not only at the plasma membrane and on the endocytic
pathway, but even in the early stage of secretory transport between
the endoplasmic reticulum and the Golgi complex [39]. During their
transport through the secretory sorting pathways, lipid rafts selec-
tively attract and so compartmentalize speciﬁc cellular proteins, par-
ticularly glycosylphosphatidylinositol (GPI)-anchored proteins and
certain fatty acylated (palmitoylated/farnesylated/myristoylated)
proteins [36,40]. The resulting clustering of proteins at outer mem-
branes is modulated and stabilized by the actin cytoskeleton [41]
and forms the basis for the functional grouping of proteins during a
wide range of processes, from cellmigration and intracellular trafﬁcking
[42] to embryonic stem cell renewal [43] and signal transduction [44].
Most pertinent to this review is the widespread function of lipid
rafts in signal transduction processes. The value of lipid rafts in facil-
itating signal transduction is clear: a raft provides a microenviron-
ment for localized signaling processes, permitting the grouping of
signaling receptors and associated signaling proteins in an isolated
and concentrated region [44]. In particular, isolated raft regions attract
individual signaling receptors (many of which are GPI-anchored,
e.g. CD14) and selectively recruit associated signaling kinases and
guanosine triphosphatases (GTPases) (e.g. dually acylated Src kinases
and the palmitoylated/farnesylated GTPase H-Ras), while actively ex-
cluding proteins such as membrane phosphatases that could interfere
with signal transduction [44,45]. A cell can thus regulate signal transduc-
tion by modifying the post-translational processing of signaling proteins
to change their recruitment to lipid rafts. When one considers the regu-
lation capabilities afforded by the fact that certain signaling proteins only
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tion in certain GPI-anchored proteins may actually depend on raft asso-
ciation [44,46], the full value of lipid rafts as the functional organizers
of cellular signaling becomes clear. It is not surprising then that lipid
rafts have been linked to a wide variety of intracellular signaling pro-
cesses, including T-cell antigen receptor signaling, Ras signaling, immu-
noglobulin E signaling, and tumor necrosis factor receptor (TNFR)
signaling [45,47]. In short, the spatial segregation afforded by lipid
rafts facilitates the efﬁciency and regulation of signaling processes
throughout the cell.
3.2. Myosin 1c regulates lipid raft trafﬁcking
Previous ﬁndings that myosin 1c binds to PI(4,5)P2, a phospholipid
enriched in lipid rafts [17], and localizes to lipid rafts in podocytes [28]
set the stage for a recent study probing the general relationship be-
tween myosin 1c and lipid rafts [35]. In this study, Brandstaetter et al.
conﬁrm the spatial association of myosin 1c with lipid rafts by demon-
strating that myosin 1c colocalizes with GPI-anchored raft markers at
the plasma membrane and on intracellular recycling tubules in live
cells, as well as co-fractionates with raft markers in a ﬂotation assay.
The study then demonstrates that siRNA knockdown of myosin 1c re-
duces levels of lipid raft-linked proteins at the plasma membrane
(and concentrates these proteins in a perinuclear recycling compart-
ment), while overexpression of myosin 1c increases the proportion of
lipid rafts at the plasma membrane. The functional role thus indicated
for myosin 1c in the exocytosis of lipid rafts from the perinuclear
recycling compartment is further supported by the demonstration
that myosin 1c knockdown speciﬁcally reduces the number of cells
containing exocytic lipid raft tubules emanating from this recycling
compartment. Brandstaetter et al. speculate that myosin 1c may regu-
late lipid raft recycling by modulating the sorting of speciﬁc protein
cargo into lipid rafts at the recycling endosome or by using the tension
of the actin cytoskeleton to promote tubule formation at the recycling
endosome and fusion of lipid rafts with the plasma membrane. The
new role for myosin 1c as a regulator of the intracellular trafﬁcking
(and potentially protein composition) of the lipid rafts crucial for prop-
er signal transduction highlights myosin 1c as a broad scale regulator of
cellular signaling.
The following two subsections provide a detailed discussion of the
signaling pathways in which we now have direct evidence that myo-
sin 1c functions via lipid raft regulation.
3.3. Myosin 1c as a regulator of integrin-mediated signaling pathways
involved in cell spreading and migration
Cells characteristically spread on an extracellularmatrix by extending
membrane protrusions such as ﬁlopodia and lamellipodia/membrane
rufﬂes, and adhere to their surroundings at contact sites called focal ad-
hesions [48]. Repetition of this spreading and adhesion process in one
part of the cell while simultaneously removing adhesion sites on oppos-
ing sides of the cell forms the basis for directed cellular migration [49].
The processes of cell spreading and migration intimately rely on the
integrin receptor, a transmembrane protein that clusters at adhesion
sites to permit communication between the extracellular matrix and in-
terior of the cell. In particular, these integrins mediate signal transduc-
tion events regulating actin organization and adhesion assembly [50].
For example, a speciﬁc signal can trigger integrins to activate the tyrosine
kinase FAK (focal adhesion kinase), which facilitates activation of the ty-
rosine kinase Src. The binding of Src to the protein p130Cas recruits the
signaling adaptor Crk, which binds p130Cas. Thismediates the activation
of the Rho GTPase Rac1, which operates with the GTPase Cdc42 to acti-
vate the WASP/WAVE family of Arp2/3 complex activators and thereby
induce the actin polymerization/branching that underlies lamellipodia
and ﬁlopodia extension during spreading and migration [50,51].Likemany signaling events, these integrin-mediated signaling path-
ways regulating cell migration and spreading rely on lipid rafts [52],
which have been shown to recruit critical signaling molecules such as
Rac and Cdc42 to the plasmamembrane [53]. This recruitment is specif-
ically triggered by integrin engagement, and the disruption of raft
targeting results in a loss of downstream signaling [53]. Rafts have
also been cited for their ability to concentrate the signaling molecules
necessary for migration/spreading, thereby promoting efﬁcient and
rapid signal transduction [54]. For example, Src kinases are activated
within lipid rafts [55] and the Rho kinasesmediating focal adhesion for-
mation cluster with Src in these rafts [56]. In fact, intact rafts are re-
quired for prolonged activation of Rac and actin polymerization [57].
Furthermore, the differential sorting of signaling molecules into lipid
rafts at the front versus rear of the cell permits the spatial segregation
of directed forward movement [54]. The overall importance of lipid
rafts in these signaling processes is further supported by the observa-
tion that disruption of lipid rafts completely abolishes lamellipodia for-
mation and migration in MCF-7 cells [54].
The role played by myosin 1c in the regulation of lipid raft recycling
indicates that this motor protein also regulates the integrin signaling
pathways underlying cell migration and spreading. A lipid raft based
role for myosin 1c in these cellular signaling pathways is reinforced by
the observation that knockdown of myosin 1c dramatically reduces
cell spreading and causes a reduction in lipid raftmarkers at the cell sur-
face of spreading HeLa cells [35]. Myosin 1c knockdown also results in
the redistribution of focal adhesions, aswell as a reduction in themigra-
tion speed and track length of migrating cells [28,35]. These ﬁndings
thus indicate a clear role for myosin 1c in mediating integrin-based sig-
naling pathways via a regulation of lipid raft recycling (Fig. 1 (1)).
3.4. Myosin 1c as a regulator of the signaling pathways involved in
macropinocytic pathogen entry
A virus or bacteria entering a given cell may use the cell's own
endocytic machinery to bypass the plasma membrane. In particular,
an increasing number of studies show that many pathogens infect a
cell via uptake into macropinosomes, large vesicles formed by mem-
brane rufﬂing that traditionally function in ﬂuid uptake [58,59]. The
entire process of macropinocytosis relies on activation from an exter-
nal signal, generally stimulation by a growth factor (e.g. epidermal
growth factor) or tumor promoting factor (e.g. phorbol myristate
acetate) [59]. In addition to the integrin-based signaling pathways
for actin regulation discussed above, the entry of different pathogens
by macropinocytosis involves a diverse set of signaling pathways,
each with their own characteristic collection of molecular players
[58]. For example, the uptake of vaccinia virus by macropinocytosis
activates a signaling cascade including the GTPases Rac1 and RhoA,
protein kinase C, and the membrane protein and kinase substrate
ezrin [60]. This signaling cascade speciﬁcally forms the actin and
ezrin containing cell protrusions necessary for vaccinia virus entry
[60]. In another example, the closure of macropinosomes during the
uptake of adenovirus 3 requires a signaling cascade in which the
Rac1 GTPase activates PAK1 (p21-activated kinase 1) and PAK1 sub-
sequently activates CtBP1 (C-terminal binding protein 1) [58,61].
As one might expect, lipid rafts are also implicated in the signaling
processes involved in macropinosome formation for pathogen entry
[62,63]. Spatial segregation of signaling proteins within a raft facilitates
efﬁcient signaling along these pathways and pathogens themselves can
subvert these carefully clustered signaling platforms for their own use
[64,65]. For example, PAK1 (p21-activated kinase 1) and the GTPase
Rac are clustered within lipid rafts in a manner that facilitates signaling
processes involving these proteins [66]. Indeed, cholesterol-mediated
disruption of lipid rafts at the plasma membrane has been suggested
to interfere with both adenovirus and human immunodeﬁciency virus
entry by disrupting the organization of relevant proteins and signaling
molecules [63,67]. Similarly, defects in lipid raft trafﬁcking have been
Fig. 1.Myosin 1c in cellular signaling pathways. This ﬁgure provides an overview of the cellular signaling pathways involving myosin 1c function. In particular, myosin 1c has been
shown to play a role in (1) the integrin-mediated signaling pathways underlying cell migration, (2) the signaling events facilitating pathogen uptake by macropinocytosis, (3) the
Neph1 translocation and signaling mediating podocyte foot formation, (4) the tumor necrosis factor-alpha (TNF-α)-induced insulin resistance pathways, (5) insulin-stimulated
GLUT4 transport to the plasma membrane, and (6) mechanical signal transduction in the hair cells of the inner ear. The molecular role of myosin 1c in each pathway is outlined and ad-
ditional key signaling players are displayed for reference. This presentation of the diverse assembly of signaling pathways involving myosin 1c function highlights the importance of this
motor in cellular signaling. Abbreviations: FAK (focal adhesion kinase), PAK1 (p21-activated kinase 1), CtBP1 (C-terminal binding protein 1), Nck (non-catalytic region of tyrosine kinase
adaptor protein 1), Grb2 (growth factor receptor-bound protein 2), IKK (IκB kinase), IRS-1 (insulin receptor substrate 1), CaMKII (Ca2+/calmodulin-dependent protein kinase II), Ca2+
(Calcium), ATP (adenosine triphosphate), and PIP2 (phosphatidylinositol 4,5-bisphosphate).
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proper formation of macropinosomes during Salmonella entry and to
block the macropinocytic uptake of this pathogen [68].
The signaling pathways for macropinocytic pathogen uptake are
thus another distinct example of a cellular signaling process that re-
quires proper lipid raft regulation. This directly implies a role for my-
osin 1c in the regulation of these signaling pathways via its role in
lipid raft recycling. Such a role for myosin 1c is supported by studiesdemonstrating that myosin 1c colocalizes with membrane rufﬂes at
the lipid raft-rich entry sites of the bacterial pathogen Salmonella
enterica, and that a knockdown of myosin 1c reduces the formation
of macropinosomes and inhibits Salmonella invasion [35]. Myosin 1c
is thus strongly implicated as a player in the signal transduction path-
ways governing pathogen entry by macropinocytosis (Fig. 1 (2)).
Thus, in summary, this section has discussed the suggestion that
the newfound role for myosin 1c in lipid raft regulation makes this
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idence speciﬁcally indicates lipid raft based functions for myosin 1c
in the integrin-mediated pathways involved in cell spreading and mi-
gration, as well as in the signaling cascades involved in pathogen up-
take by macropinocytosis. Given the widespread involvement of lipid
rafts in cell signaling, these pathways are likely to be only a few of the
cellular signaling pathways in which myosin 1c plays a lipid raft-based
role.4. Further roles for myosin 1c in cell signaling
In addition to the function of myosin 1c in speciﬁc signaling path-
ways linked to its role in lipid raft recycling, myosin 1c has also been
suggested to play a more direct role in other intracellular signaling
cascades by mediating the delivery of lipid raft associated signaling
components or by acting as a direct player in signal transduction.4.1. Myosin 1c in Neph1 signaling
The podocyte (visceral epithelial) cells of the kidneys characteristi-
cally extend foot-like, actin-based projections that wrap around the
capillary network within the glomerulus. Blood passing through these
capillaries is pressure ﬁltered through the slits between these foot-like
projections [69] (See Fig. 1 (3)). The formation of such actin-based
foot projections at the podocyte membrane relies on a signaling trans-
duction cascade involving the transmembrane proteins Neph1 and
nephrin. In particular, activation of a nephrin–Neph1 complex by the
Src family protein kinase Fyn results in recruitment of the adaptor pro-
teins Nck (non-catalytic region of tyrosine kinase adaptor protein
1) and Grb2 (growth factor receptor-bound protein 2) that regulate
actin polymerization via WASP proteins and the Arp2/3 complex [70].
Recently it has been shown that myosin 1c binds both Neph1 and
nephrin and mediates their localization to outer membranes, and that
myosin 1c depletion disrupts this localization and so the signaling path-
ways necessary to form the actin structures required for podocyte mi-
gration [28]. Arif et al. suggest that this involvement of myosin 1c in
Neph1 signaling stems from the fact that myosin 1c recruits the
Neph1–nephrin complex to lipid rafts for membrane delivery and sig-
naling compartmentalization andmay also be involved in the anchoring
of the Neph1 complex at the plasma membrane.4.2. Myosin 1c in tumor necrosis factor-alpha (TNF-alpha) induced insulin
resistance
One of the leading risk factors for the development of type 2 diabetes
is resistance to insulin-stimulated glucose uptake or ‘insulin resistance’
[71]. The development of insulin resistance in a given cell relies on a
signaling pathway involving adipocytokine TNF-α activation of IκB
kinase (IKK) and eventual phosphorylation of IRS-1 (insulin receptor
substrate 1), which reduces the metabolic response to insulin [72,73]
(See Fig. 1 (4)). The involvement of myosin 1c in this signaling pathway
has been clearly demonstrated [74]. Myosin 1c binds to a subunit of IKK
(nuclear factor κB essential modulator (NEMO)/IKK-γ) and is required
for the translocation of this protein to its functional site at the plasma
membrane. Overexpression of a dominant negative formofmyosin 1c re-
duces the interaction between IKK and IRS-1 and reduces phosphoryla-
tion of IRS-1, suggesting clearly that the motor mediates TNF-α-induced
down-regulation of IRS-1 and glucose uptake [74]. Myosin 1c may play
a role in this signaling pathway by mediating lipid raft based transport
of NEMO/IKK-γ or clustering of TNF-α pathway signaling molecules at
the membrane. Alternatively, the myosin 1c-NEMO complex could play
a direct functional role in the signaling cascade that mediates phosphor-
ylation of IRS-1 [74].4.3. Myosin 1c as a direct player in insulin-mediated signaling for glucose
receptor transport
Glucose uptake into adipocyte and muscle cells involves insulin
hormone-stimulated transfer of GLUT4 (glucose transporter 4) to the
plasma membrane. GLUT4 is a glucose transporter that directly facili-
tates glucose uptake [75]. The transfer of GLUT4 occurs via a series of
signaling cascades characteristically involving the serine/threonine ki-
nase Akt [76]. The involvement of myosin 1c in the translocation of
GLUT4 containing vesicles to the plasma membrane of both adipocytes
and skeletalmuscle cells iswell established [24,77] (See Fig. 1 (5)). A re-
cent study demonstrates that the role formyosin 1c in GLUT4 transloca-
tion is based on the direct involvement of this motor as a novel target in
an insulin signaling pathway [78]. In particular, insulin stimulation acti-
vates the serine/threonine kinase CaMKII (Ca2+/calmodulin-dependent
protein kinase II) by increasing the calcium concentration beneath the
plasma membrane. CaMKII then phosphorylates myosin 1c at Ser701,
and myosin 1c binds a 14-3-3 regulatory protein. This results in an in-
crease in the ATPase activity of myosin 1c, which may facilitate the
docking or fusion of GLUT4 vesicles at the plasma membrane. This
new myosin 1c-dependent signaling pathway is critical for proper
GLUT4 transfer and the resulting uptake of glucose, as abolishment of
this pathway using CaMKII inhibitors blocks insulin-stimulated glucose
transport in adipocytes [78].
Myosin 1c is thus involved in cell signaling pathways not only via
lipid raft regulation and protein anchoring/transfer, but also as a direct-
ly phosphorylated player in an insulin-mediated signaling cascade. In
fact, the role of myosin 1c as an insulin-regulated 14-3-3 target in this
pathway has led to the speculation that the motor may be phosphory-
lated by other Ca2+/calmodulin-dependent protein kinases in other
similar transduction pathways [79].4.4. Myosin 1c in mechanical signal transduction in hair cells
Mechanical signal transduction or ‘mechanotransduction’ is a spe-
cialized type of cellular signaling event in which mechanical signals
are converted into biochemical responses. In the hair cells of the inner
ear, this signaling process permits the transfer of the mechanical vibra-
tions passing through the ear canal into electrical stimuli that travel
along neurons to signal the brain [80]. In particular, a mechanical
sound stimulus causes the physical deﬂection of specialized microvilli
termed stereocilia and so generates a change in tension that opens a se-
ries of tension-gated ion channels at the tips of the stereocilia [23]. The
resulting inﬂux of calcium ions through these ion channels induces a
membrane depolarization that triggers a neurotransmitter release and
so activates adjacent auditory nerve ﬁbers [80] (See Fig. 1 (6)). This in-
ﬂux of calcium can occur on a short time scale (a few milliseconds or
less before channel closure) or a longer time scale (more than 10 milli-
seconds before channel closure). These processes are termed fast and
slow adaptation, respectively [81].
Myosin 1c has been regarded as a key player in mechanical signal
transduction in hair cells for many years now. During slow adaptation,
myosin 1c motors connected to the stereocilia membrane slide along
actin ﬁlaments to reduce the tension on the gated ion channels caused
by stereocilia displacement, thereby permitting channel closure and sig-
nal attenuation [23]. This tension-modulating role for myosin 1c in me-
chanical signal transduction is believed to be regulated by calcium, ATP,
and the phosphatidylinositol 4,5-bisphosphate (PIP2) in the stereocilia
membrane [82,83]. The ﬁnding that expression ofmutantmyosin 1c con-
structs in hair cells blocks not only slow adaptation but also fast adapta-
tion suggests that the well-studied role for myosin 1c in slow adaptation
may be complemented by a similar role in fast adaptation [84,85]. The
overall importance of myosin 1c in this signaling process is conﬁrmed
by the observation that mutations in myosin 1c are linked to hearing
loss in the human population [86].
234 L.M. Bond et al. / Cellular Signalling 25 (2013) 229–235This function for myosin 1c in mechanical signal transduction in the
inner ear demonstrates that myosin 1c can play a role in cellular signal-
ing directly based on its capabilities for tethering and force generation.
Interestingly, preliminary evidence indicates that myosin 1c may also
regulate signal transduction via ion channels in different body systems,
as proper myosin 1c function is necessary for normal transport through
sodium ion channels in collecting duct cells upon antidiuretic hormone
(ADH) stimulation [29].
5. Myosin 1c in cell signaling and disease
Considerable evidence now indicates that defects in cellular signal-
ing pathways are intimately linked to disease. For example, defects in
the integrin signaling pathways mediating adhesion and migration
have been implicated in rheumatoid arthritis, inﬂammatory bowel dis-
ease, andmuscular dystrophy [87], while over expression of integrins is
linked to tumor growth in many forms of cancer [88]. Similarly, defects
in proper insulin signaling and the signaling pathways leading to insulin
resistance are directly linked to the onset of type 2 diabetes, obesity,
and Alzheimer's disease [89,90]. Furthermore, defects in Neph1 sig-
naling pathways in podocytes have been linked to focal segmental
glomerulosclerosis and membranous nephropathy [91,92], and defects
in mechanical signal transduction in hair cells cause deafness [93].
The newly emerging importance ofmyosin 1c in each of these signal-
ing pathways (andmanymore) thus implicates thismotor as a target for
drug-based treatment ofmany critical human diseases, fromAlzheimer's
disease to diabetes. For example, targeted reduction of functionalmyosin
1c levels could combat overexpression of insulin-mediated signaling
pathways in tumor migration. In addition, therapeutic restoration of
functional myosin 1c could restore proper mechanical signal transduc-
tion in deaf individuals. The amenability of myosin 1c to drug-based
therapies is supported by a recent study showing that the motor activity
and intracellular trafﬁcking functions of myosin 1c can be inhibited by
the small molecule pentachloropseudilin [94]. In short, the important
role played by myosin 1c in cellular signaling makes this motor a valu-
able new drug target for the treatment of many diseases.
6. Conclusions
• The molecular motor myosin 1c is a prominent player in many sig-
nal transduction pathways throughout the cell, from the integrin-
mediated pathways involved in cell migration to the Neph1 signaling
pathways involved in actin organization in podocytes.
• The role played by myosin 1c in many of these pathways is based on
the fact that this motor regulates the intracellular recycling of lipid
rafts, which serve as important platforms for the organization and
coordination of proper signaling throughout the cell.
• Myosin 1c also plays amore direct role in intracellular signaling, e.g. as
a phosphorylated member of the signaling transduction pathways
mediating GLUT4 trafﬁcking and as a tension-based modulator of
mechanical signal transduction in the inner ear.
• Defects in all of these signaling events cause distinct forms of human
disease. As such, the role of myosin 1c as a new player in intracellular
signaling makes this motor an important target for drug-based
therapeutics.
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